4TZ-21420-18781
2 vaccinations
1 coded response
13 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 021 / MA
- Registered
- 2021-08-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-23
Dose 1 — Pfizer-BioNTech
-
2021-08-11
Registered in v-safe
- 2021-08-11
-
2021-08-13
Dose 2 — Pfizer-BioNTech
- 2021-08-13
-
2021-08-14
Survey response — days 1–6 daily, dose 2MedDRA: Dyspnoea, Heart rate increased — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Shortness of breath; increased heart rateMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness, DiarrheaAdult check-in
- 2021-08-16
- 2021-08-17
- 2021-08-20
- 2021-08-27
- 2021-09-03
- 2021-09-17
- 2021-09-24
- 2021-11-14
- 2022-02-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-23 | Pfizer-BioNTech | No |
| 2 | 2021-08-13 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Shortness of breath; increased heart rate
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Dyspnoea | ✓ | · | ✓ |
| SRO | Heart rate increased | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release